Physician profile
Robert Arthur Cusick
NPI 1295793800
$922.33
in general payments reported to CMS, 2019-2025
14 companies · $319 in 2025
The $319 reported for 2025 was more than what a typical Pediatric Surgery provider received nationally (typical 2025 total: $136).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $104 · 2021: $26.44 · 2022: $42.18 · 2023: $277 · 2024: $153 · 2025: $319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $749.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $749.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $248.55 | 2024-2025 | Echelon Flex, Ethicon |
| Atricure, INC. | $216.75 | 2022-2023 | |
| Kls-Martin L.P. | $75.84 | 2025 | |
| Conmed Corporation | $70.71 | 2024-2025 | Airseal |
| W. L. Gore & Associates, INC. | $68.69 | 2023 | Gore Seamguard Bioabsorbable Staple Line Reinforce |
| Hologic Sales and Service, LLC | $58.95 | 2025 | Coolseal Generator |
| Ethicon US, LLC | $44.40 | 2019-2024 | Echelon Endopath, Echelon Circular, Ethicon |
| Asensus Surgical, INC. | $44.38 | 2019 | |
| Covidien LP | $20.51 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.97 | 2022 | |
| Stryker Corporation | $14.69 | 2023 | Verasense |
| Pacira Pharmaceuticals Incorporated | $14.10 | 2021 | |
| Teleflex LLC | $13.45 | 2019 | |
| Applied Medical Technology INC | $12.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Cusick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.